Skip to content

Trevi Therapeutics, Inc. TRVI Proceeds From Warrant Exercises

Proceeds From Warrant Exercises at other companies

TRV
Trevi Therapeutics, Inc.TRVI
$2.54M
AvePoint, Inc. logo
AvePoint, Inc.AVPT
$0-100%
Rigetti Computing, Inc. logo
Rigetti Computing, Inc.RGTI
$30K-92.7%
KEE
Keel Infrastructure Corp. Common StockKEEL
$11.48M
SoundHound AI, Inc. logo
SoundHound AI, Inc.SOUN
$0-100%
Tidewater logo
TidewaterTDW
$0-100%

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.47B+152%
Enterprise value$2.45B+157%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Reported directly by Trevi Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromWarrantExercises.

The official record: Trevi Therapeutics, Inc.’s 10-Q, filed August 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about Trevi Therapeutics, Inc.'s proceeds from warrant exercises.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trevi Therapeutics, Inc.'s proceeds from warrant exercises?
Trevi Therapeutics, Inc. (TRVI) reported proceeds from warrant exercises of $2.54M in Q2 2025.
What does proceeds from warrant exercises mean?
Indicates the cash inflows resulting from the exercise of outstanding warrants by investors to purchase company stock. This serves as a source of non-dilutive or secondary capital that strengthens the company's cash position.